Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ardent Health Partners Q2 EPS $0.52, Inline, Sales $1.645B Beat $1.598B Estimate

Author: Benzinga Newsdesk | August 05, 2025 03:31pm
Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 52.94 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $1.645 billion which beat the analyst consensus estimate of $1.598 billion by 2.94 percent. This is a 11.83 percent increase over sales of $1.471 billion the same period last year.

Posted In: ARDT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist